Patent details

Basic Information

Publication number:

EP2027103

PCT Application Number:

PCT/EP/2007/005008

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP077258663

PCT Publication Number:

WO/2007/144097

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

NEW CHIRAL INTERMEDIATE, PROCESS FOR PRODUCING THE SAME AND ITS USE IN THE MANUFACTURE OF TOLTERODINE, FESOTERODINE, OR THE ACTIVE METABOLITE THEREOF

French Title of Invention:

NOUVEL INTERMÉDIAIRE CHIRAL, SON PROCÉDÉ DE FABRICATION ET SON UTILISATION DANS LA FABRICATION DE TOLTÉRODINE, FÉSOTÉRODINE, OU DE SON MÉTABOLITE ACTIF

German Title of Invention:

NEUES CHIRALES ZWISCHENPRODUKT, HERSTELLUNGSVERFAHREN DAFÜR UND SEINE VERWENDUNG BEI DER HERSTELLUNG VON TOLTERODIN, FESOTERODIN ODER DES AKTIVEN METABOLITEN DAVON

SPC Number:

Dates

Filing date:

06/06/2007

Grant date:

26/02/2014

EP Publication Date:

26/02/2014

PCT Publication Date:

21/12/2007

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

25/02/2009

EP B1 Publication Date:

26/02/2014

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

06/06/2014

Expiration date:

06/06/2027

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

06/06/2007

 

 

Name:

UCB Pharma GmbH

Address:

Alfred-Nobel-Strasse 10, 40789 Monheim, Germany (DE)

Inventor

Name:

MEESE Claus

Address:

Germany (DE)

Priority

Priority Number:

06012052

Priority Date:

12/06/2006

Priority Country:

European Patent Office (EPO) (EP)

Classification

Main IPC Class:

C07D 311/20;

Filing date	Document type	Number of pages